Vaccination is Australia's most important COVID-19 public health action, even though herd immunity is unlikely
McBryde, E. S.; Meehan, M. T.; Sziklay, J.; Adekunle, A.; Kuddus, A.; Ogunlade, S.; Jayasundara, P.; Ragonnet, R.; Trauer, J. M.; Cope, R. C.
Show abstract
The Australian National Cabinet four-step plan to transition to post-pandemic re-opening begins with vaccination to achieve herd protection and protection of the health system against a surge in COVID-19 cases. Assuming a pre-vaccination reproduction number for the Delta variant of 5, we show that for the current Mixed program of vaccinating over 60s with AstraZeneca and 16-60s with Pfizer we would not achieve herd immunity. We would need to cover 85% of the population (including many 5-16 year-olds to achieve herd immunity). At lower reproduction number of 3 and our current Mixed strategy, we can achieve herd immunity without vaccinating 5-15 year olds. This will be achieved at a 60% coverage pursuing a strategy targetting high transmitters or 70% coverage using a strategy targetting the vulnerable first. A reproduction number of 7 precludes achieving herd immunity, however vaccination is able to prevent 75% of deaths compared with no vaccination. We also examine the impact of vaccination on death in the event that herd immunity is not achieved. Direct effects of vaccination on reducing death are very good for both Pfizer and AstraZeneca vaccines. However we estimate that the Mixed or Pfizer program performs better than the AstraZeneca program. Furthermore, vaccination levels below the herd immunity threshold can lead to substantial (albeit incomplete) indirect protection for both vaccinated and unvaccinated populations. Given the potential for not reaching herd immunity, we need to consider what level of severe disease and death is acceptable, balanced against the consequences of ongoing aggressive control strategies. O_TEXTBOXThe known: SARS CoV-2 variants are known to be more transmissible than the original Wuhan strain, making herd immunity challenging. The new: We find that vaccinating the older-vulnerable age groups first leads to fewer deaths and is the optimal strategy vaccine coverage is under 70%. Herd immunity achieved solely through vaccinating adults is unlikely, but can still be expected to prevent substantial numbers of deaths. The implications: Australia is unlikely to achieve herd immunity unless vaccination is combined with substantial public health measures. Even without herd immunity, vaccination remains a highly effective means to mitigate the impact of COVID-19. C_TEXTBOX
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cost-effectiveness of routine COVID-19 adult vaccination programmes in England 96%
- Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework 96%
- Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19 96%
Similar papers in this journal
Similar papers in this journal
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 97%
- Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study 95%
- An assessment of the vaccination of school-aged children in England 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.